Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Denosumab by Amgen for Osteoarthritis: Likelihood of Approval
Denosumab is under clinical development by Amgen and currently in Phase II for Osteoarthritis. According to GlobalData, Phase II drugs...
Denosumab by Amgen for Metastatic Melanoma: Likelihood of Approval
Denosumab is under clinical development by Amgen and currently in Phase II for Metastatic Melanoma. According to GlobalData, Phase II...
Denosumab by Amgen for Male Infertility: Likelihood of Approval
Denosumab is under clinical development by Amgen and currently in Phase II for Male Infertility. According to GlobalData, Phase II...